Foreign establishment registration
This article was originally published in The Gray Sheet
Proposed rule issued May 14 would require all foreign establishments whose products are imported or offered for import into the U.S. to register with FDA, as required by Sec. 417 of the FDA Modernization Act. Prior to FDAMA, foreign manufacturers were required only to list their U.S. marketed products with the agency
You may also be interested in...
Azar says ACIP’s prioritization recommendations should carry weight, but states will be final arbiter of who is vaccinated.
Sanofi R&D head John Reed says the company has kept 95% of patients on its nearly 400 clinical trials, started 59 studies, and benefited from its in-house drug supply management.
The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.